Bio-manufacturing Conference 2015

27 Oct - 28 Oct 2015

The disposable biomanufacturing industry has grown exponentially over the past decade, and it continues to revolutionise how biotherapeutics are manufactured today. The last few years has seen a rapid shift in single use systems. The Disposables market is estimated to be worth $300 billion in 2016.

Having gained the strong growth momentum, the global biopharmaceutical market has been expected to further grow at a fast pace in the foreseeable future, in particular since the development of novel therapeutic antibodies has become an industry-wide focus. The global biopharmaceutical market is forecasted to experience a CAGR of approximately 11.8% from 2014 to 2018 and could reach $344 billion by 2018, possibly accounting for approximately 27% of the total global pharmaceutical market by then. Of the forecasted global biopharmaceutical market, the fastest growth sector is expected to be the therapeutic antibody market, which is forecasted to reach $120 billion by 2018, representing a CAGR of approximately 14% during this time period.

Driven by the fast growth of the global biopharmaceutical market, the demand for biomanufacturing outsourcing services has increased rapidly in recent years. Although the majority of the biomanufacturing outsourcing activities are still centered on such tasks as cell line development, bioanalysis, product characterization, and biosafety testing, the industry-wide growing demand for manufacturing service of developmental biologics is being clearly demonstrated.

At present most major companies are still investing to expand their internal biomanufacturing capacities. Some R&D-focused small biopharma companies are also attempting to build their own biomanufacturing facilities encouraged by the reduced cost and setup time provided by the more advanced single-use bio-equipment. Coupled with the short history of the global biomanufacturing outsourcing industry, the current industry-wide average penetration of biomanufacturing outsourcing is approximately 10%; and the current global market of the biomanufacturing service is approximately $4.9 billion. In the past five years (2009−2013), it has been growing in a CAGR of about 11%.